a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Encephalopathy
- Epilepsy
- Neuropathy
- Prostate Cancer
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Retrospective
Participation Requirements
- Age
- Younger than 100 years
- Gender
- Both males and females
Description
Enzalutamide are responsible of a wide range of side effects.The investigators use VigiBase, the World Health Organization (WHO) database of individual safety case reports, to identify cases of adverse drug reactions following treatment with enzalutamide
Enzalutamide are responsible of a wide range of side effects.The investigators use VigiBase, the World Health Organization (WHO) database of individual safety case reports, to identify cases of adverse drug reactions following treatment with enzalutamide
Tracking Information
- NCT #
- NCT04290611
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon